Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combinatorial cancer immunotherapy.

F Stephen Hodi1, Glenn Dranoff

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Advances in Immunology
|May 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting immune-related thyroiditis using polygenic risk scores in patients with advanced melanoma.

Journal for immunotherapy of cancer·2026
Same author

Immune Checkpoint Inhibitor Esophagitis: Clinical and Endoscopic Presentation, Treatment Outcomes, and Complications.

Clinical and translational gastroenterology·2026
Same author

Same-Slide Spatial Multi-Omics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment.

Cancer discovery·2026
Same author

Insights into inherited genetic variations and genetic ancestry of patients with high-risk melanoma.

Melanoma research·2026
Same author

Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer.

Cancer cell·2026
Same author

Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Enhancing cancer immunology treatments, like whole tumor cell vaccines and CTLA-4 blockade, aims to boost anti-tumor immunity. Combinations may improve tumor destruction while minimizing autoimmune side effects.

Area of Science:

  • Cancer Immunology
  • Immunotherapy
  • Tumor Biology

Background:

  • Cancer immunology seeks to improve immune-mediated tumor destruction.
  • Current immunotherapies include vaccines, antibodies, cytokines, and cellular infusions.
  • Despite progress, many patients still experience disease progression.

Purpose of the Study:

  • To review novel immunotherapies targeting key control points in anti-tumor immunity.
  • To discuss genetically modified whole tumor cell vaccines and CTLA-4 blockade.
  • To explore combinatorial approaches for enhanced tumor destruction.

Main Methods:

  • Analysis of clinical trial data and murine tumor models.
  • Investigation of dendritic cell activation pathways.
  • Evaluation of antibody blockade of cytotoxic T lymphocyte-associated antigen-4 (CTLA-4).

Related Experiment Videos

Main Results:

  • Efficient dendritic cell activation and inhibition of negative immune regulation are crucial for therapeutic success.
  • Genetically modified whole tumor cell vaccines and CTLA-4 blockade represent promising therapeutic strategies.
  • Early clinical data suggest combinatorial approaches may be effective.

Conclusions:

  • Targeting dendritic cell activation and negative immune regulation can enhance anti-tumor immunity.
  • Combinatorial immunotherapies hold potential for significant tumor destruction.
  • Future strategies may achieve efficacy without severe autoimmune complications.